Analysts who follow Tonix Pharmaceuticals Holding Corp (TNXP) on average expect it to add 293.94% over the next twelve months. Those same analysts give the stock an average rating of Buy.
That average rating puts the stock higher than 40 of stocks, based on data compiled by InvestorsObserver.
Click Here to get the full report on Tonix Pharmaceuticals Holding Corp (TNXP) Stock.
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Tonix Pharmaceuticals Holding Corp Stock Today?
Tonix Pharmaceuticals Holding Corp (TNXP) stock is trading at $1.65 as of 9:47 AM on Tuesday, Jan 28, an increase of $0.01, or 0.61% from the previous closing price of $1.64. The stock has traded between $1.60 and $1.67 so far today. Volume today is below average. So far 50,360 shares have traded compared to average volume of 2,999,380 shares.
